mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors

Abstract Background Despite advancements in the successful use of immunotherapy in treating a variety of solid tumors, applications in treating brain tumors have lagged considerably. This is due, at least in part, to the lack of well-characterized antigens expressed within brain tumors that can medi...

Descrición completa

Detalles Bibliográficos

Principais autores:	Vrunda Trivedi, Changlin Yang, Kelena Klippel, Oleg Yegorov, Christina von Roemeling, Lan Hoang-Minh, Graeme Fenton, Elizabeth Ogando-Rivas, Paul Castillo, Ginger Moore, Kaytora Long-James, Kyle Dyson, Bently Doonan, Catherine Flores, Duane A. Mitchell
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-01-01
Series:	Genome Medicine
Assuntos:	Personalized immunotherapy Cancer immunity mRNA therapeutics Vaccines Adoptive T cell therapy Immune checkpoint blockade
Acceso en liña:	https://doi.org/10.1186/s13073-024-01281-z
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!